Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,255.00
-10.00 (-0.23%)
Last updated: Jun 9, 2025
4.55%
Market Cap 91.82B
Revenue (ttm) 106.64B
Net Income (ttm) 1.65B
Shares Out 21.71M
EPS (ttm) 12.28
PE Ratio 55.79
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 302,424
Average Volume 3,047,317
Open 4,275.00
Previous Close 4,265.00
Day's Range 4,170.00 - 4,300.00
52-Week Range 3,090.00 - 6,950.00
Beta 0.60
RSI 51.64
Earnings Date Aug 14, 2025

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2024, KOSDAQ:142280's revenue was 103.85 billion, an increase of 10.47% compared to the previous year's 94.01 billion. Earnings were 3.58 billion, an increase of 99.25%.

Financial Statements

News

There is no news available yet.